Literature DB >> 15958530

Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.

Dohun Pyeon1, Paul F Lambert, Paul Ahlquist.   

Abstract

Papillomaviruses are small DNA viruses that are associated with benign and malignant epithelial lesions, including >95% of cervical cancers and approximately 20% of head and neck cancers. Because papillomavirus replication and virion production are tied to epithelial cell differentiation, infectious papillomavirus virion production has been limited to cumbersome organotypic cultures and mouse xenografts. Consequent difficulties in obtaining useful amounts of wild-type or mutant human papillomavirus (HPV) virions have greatly limited studies on many aspects of papillomavirus biology. To overcome these limitations, we developed a system to encapsidate the full-length papillomaviral genome into infectious virions, independently of viral DNA replication and epithelial differentiation. This transient-transfection-based system produces >1,000 times more infectious virus per cell culture dish than the much more labor-intensive organotypic culture. Furthermore, we show that this method allows the facile generation of infectious particles containing wild-type, mutant, or chimeric papillomaviral genomes, overcoming barriers to studying many facets of replication, host interactions, and vaccine and drug development, which has been limited by the insufficient availability of infectious virions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958530      PMCID: PMC1166641          DOI: 10.1073/pnas.0504020102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Human papillomavirus type 45 propagation, infection, and neutralization.

Authors:  Margaret E McLaughlin-Drubin; Susan Wilson; Brian Mullikin; JoAnn Suzich; Craig Meyers
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

3.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

4.  A causal role for human papillomavirus in head and neck cancer.

Authors:  M L Gillison; D R Lowy
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

5.  Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line.

Authors:  J Doorbar; A Parton; K Hartley; L Banks; T Crook; M Stanley; L Crawford
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

6.  Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.

Authors:  Nina Mossadegh; Lutz Gissmann; Martin Müller; Hanswalter Zentgraf; Angel Alonso; Pascal Tomakidi
Journal:  Virology       Date:  2004-08-15       Impact factor: 3.616

7.  Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.

Authors:  S C Dollard; J L Wilson; L M Demeter; W Bonnez; R C Reichman; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

Review 8.  Pathogenesis of human papillomaviruses in differentiating epithelia.

Authors:  Michelle S Longworth; Laimonis A Laimins
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

9.  Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

Authors:  Saeed Shafti-Keramat; Alessandra Handisurya; Ernst Kriehuber; Guerrino Meneguzzi; Katharina Slupetzky; Reinhard Kirnbauer
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  70 in total

1.  Phosphorylation of the Human Papillomavirus E2 Protein at Tyrosine 138 Regulates Episomal Replication.

Authors:  Leny Jose; Elliot J Androphy; Marsha DeSmet
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

2.  Papillomavirus particles assembled in 293TT cells are infectious in vivo.

Authors:  Timothy D Culp; Nancy M Cladel; Karla K Balogh; Lynn R Budgeon; Andres F Mejia; Neil D Christensen
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  The development of quantum dot calibration beads and quantitative multicolor bioassays in flow cytometry and microscopy.

Authors:  Yang Wu; Samuel K Campos; Gabriel P Lopez; Michelle A Ozbun; Larry A Sklar; Tione Buranda
Journal:  Anal Biochem       Date:  2007-02-13       Impact factor: 3.365

4.  Human papillomaviruses: a growing field.

Authors:  Denise A Galloway
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

5.  Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.

Authors:  Laura M Griffin; Louis Cicchini; Tao Xu; Dohun Pyeon
Journal:  Methods Mol Biol       Date:  2014

6.  Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18.

Authors:  Valerie Laniosz; Kha C Nguyen; Patricio I Meneses
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

7.  Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating.

Authors:  Jessica L Smith; Samuel K Campos; Angela Wandinger-Ness; Michelle A Ozbun
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

9.  Therapeutic vaccines against human papillomavirus and cervical cancer.

Authors:  Angel Cid-Arregui
Journal:  Open Virol J       Date:  2009-10-23

Review 10.  Mechanisms of cell entry by human papillomaviruses: an overview.

Authors:  Caroline A J Horvath; Gaëlle A V Boulet; Virginie M Renoux; Philippe O Delvenne; John-Paul J Bogers
Journal:  Virol J       Date:  2010-01-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.